GSK
GSK Files Q2 Report Showing £8.4bn Sales and £1.9bn Savings Plan
GSK's 6-K restates second-quarter 2026 turnover of £8.4 billion, up 5%, alongside a three-year Accelerate Growth programme targeting £1.9 billion in annual savings by 2029.
GSK
Market-moving news on GSK (NYSE: GSK): filings, earnings, deals and other events, from REDFILED.